Berberine phospholipid exerts a positive effect on the glycemic profile of overweight subjects with impaired fasting blood glucose (IFG): a randomized double-blind placebo-controlled clinical trial.
European review for medical and pharmacological sciences（2023）
摘要
The use of berberine had no adverse events, supporting its use as a natural alternative to pharmacological therapies in the case of IFG.
更多查看译文
关键词
berberine phospholipid,glycemic profile,blood glucose,overweight subjects,double-blind,placebo-controlled
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要